Literature DB >> 19729908

A pilot, randomized, double-blind, cross-over study of high cut-off versus high-flux dialysis membranes.

Darren Lee1, Michael Haase, Anja Haase-Fielitz, Kathy Paizis, Hermann Goehl, Rinaldo Bellomo.   

Abstract

BACKGROUND: High cut-off (HCO) membranes may increase beta(2)-microglobulin (beta2M) removal compared to standard high-flux membranes.
METHODS: Eight stable haemodialysis patients were enrolled in a prospective, randomized, double-blind, cross-over study and treated with HCO and high-flux membranes for 2 weeks each, between a 1-week washout period. Primary end point was serum beta2M removal. Secondary end points included serum albumin concentrations, albumin and small solute clearances.
RESULTS: HCO membranes achieved significantly lower median post-dialysis beta2M concentration (10.8 vs. 14.2 mg/l; p = 0.003) and greater beta2M reduction ratio (62.3 vs. 51.0%; p < 0.002). Serum albumin decreased with HCO membranes (from 36 to 29.5 g/l; p = 0.018) but increased to 33.5 g/l after the washout period. Albumin clearance was significantly greater with HCO membranes (2.2 vs. 0.06 ml/min; p = 0.004). Urea reduction ratio was significantly lower with HCO membranes (64.8 vs. 71.5%; p < 0.001).
CONCLUSION: beta2M removal was superior with HCO membranes. Reduction in serum albumin and lower small solute clearance require further investigations. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19729908     DOI: 10.1159/000235961

Source DB:  PubMed          Journal:  Blood Purif        ISSN: 0253-5068            Impact factor:   2.614


  5 in total

Review 1.  High-flux versus low-flux membranes for end-stage kidney disease.

Authors:  Suetonia C Palmer; Kannaiyan S Rabindranath; Jonathan C Craig; Paul J Roderick; Francesco Locatelli; Giovanni F M Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2012-09-12

2.  An experimental and theoretical analysis of molecular separations by diffusion through ultrathin nanoporous membranes.

Authors:  J L Snyder; A Clark; D Z Fang; T R Gaborski; C C Striemer; P M Fauchet; J L McGrath
Journal:  J Memb Sci       Date:  2011-03-01       Impact factor: 8.742

3.  Septic AKI in ICU patients. diagnosis, pathophysiology, and treatment type, dosing, and timing: a comprehensive review of recent and future developments.

Authors:  Patrick M Honore; Rita Jacobs; Olivier Joannes-Boyau; Jouke De Regt; Willem Boer; Elisabeth De Waele; Vincent Collin; Herbert D Spapen
Journal:  Ann Intensive Care       Date:  2011-08-09       Impact factor: 6.925

Review 4.  Clinical review: blood purification for sepsis.

Authors:  Thomas Rimmelé; John A Kellum
Journal:  Crit Care       Date:  2011-02-16       Impact factor: 9.097

Review 5.  The role of technological progress vs. accidental discoveries and clinical experience.

Authors:  Zofia Wańkowicz
Journal:  Med Sci Monit       Date:  2013-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.